A daily, multi-theme momentum strategy that blends stocks, sector ETFs, leveraged bets, and hedges. It picks the strongest movers across tech, biotech, and macro assets, uses momentum/RSI signals to enter/exit, and rebalances to diversify risk.

What it does in simple terms: - It runs every day and looks at many different market themes (tech/momentum, biotech, general market leaders, hedges). - For each theme, it scans a list of assets (stocks and ETFs, including leveraged and inverse ones) and measures momentum using several rules (how prices rose recently, how strong the trend is, and whether the asset looks overbought or oversold). - It uses a ranking system to pick the best assets in each theme (often the top 1 or top 2). - It combines these picks into a single daily allocation, sometimes concentrating a large portion of the portfolio on the top winner but also spreading across other themed picks. Some parts of the strategy intentionally hold hedges (like volatility bets or inverse/short ETFs) to reduce risk in bad markets. - The signals come from a mix of momentum tests (relative strength, moving averages, cumulative returns) and risk checks (drawdowns, price vs. moving averages). RSI (a momentum indicator) and other momentum metrics drive entries and exits with different look-back periods depending on the asset. - Rebalancing is daily, adjusting which assets are held and how much capital each gets. - The intention is to ride trends in multiple asset classes (stocks, tech, biotech, bonds) while having built-in hedges to weather downturns.

Out-of-sample, this strategy targets higher upside than the S&P (≈24% vs ≈21.8%) through multi-theme momentum and hedges. Diversified across tech/biotech and macro assets, it seeks stronger growth with managed risk.